ARCHIVES

Herceptin Regimen Minus Adriamycin Increases Survival With Less Toxicity

This article is from The Cancer Letter archive.

Vol. 34 No. 10 | October 28, 2011

Download PDF Visit The Full Archive

Related Articles

In Brief: FDA Commissioner Kessler Named Dean, Yale Medical School, Effective July 1

February 21, 1997

UT Board Announces Support for MD Anderson Tenure System

October 10, 2014

Biostatistician Thomas Fleming Warns Against Approval of Provenge.

May 4, 2007

Varmus Pledges No Funding Gap for NCORP, Blames Snafu On “Unclear Communication”

April 11, 2014

NCI Peer Review: Consumer Advocates Named To Panels Reviewing Center Grants, ECOG Renewal

September 4, 1998

ACS Urges Bush To Increase NCI Budget.

January 19, 2007